Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial

T.F. Wijnands,Tom J. G. Gevers,Lantinga,R.H.M. te Morsche,L.J. Schultze Kool,J.P.H. Drenth

Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial

2018

T.F. Wijnands
Tom J. G. Gevers
Lantinga
R.H.M. te Morsche
L.J. Schultze Kool
J.P.H. Drenth

Objectives We tested whether complementary use of the somatostatin analogue pasireotide would augment efficacy of aspiration sclerotherapy of hepatic cysts.

Keywords:

Gastroenterology
Randomized controlled trial
Radiology
Pasireotide
Hepatic Cyst
Sclerotherapy
Somatostatin
Cyst
Medicine
Somatostatin Analogue
Internal medicine
Interventional radiology
Surgery
Clinical endpoint
Placebo

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations